Cargando…
A new personalized vaccine strategy based on inducing the pyroptosis of tumor cells in vivo by transgenic expression of a truncated GSDMD N-terminus
The variability and heterogeneity of tumor antigens and the tumor-driven development of immunosuppressive mechanisms leading to tumor escape from established immunological surveillance. Here, the tumor cells were genetically modified to achieve an inducible overexpression of the N-terminal domain of...
Autores principales: | He, Jinrong, Zheng, Peng, Chen, Yongjun, Qi, Jialong, Ye, Chao, Li, Duo, Yang, Ying, Liu, Qingwen, Hu, Yongmao, Zheng, Xiao, Li, Weiran, Hua, Liangqun, Yang, Zhongqian, Chen, Haoqian, Huang, Weiwei, Sun, Wenjia, Yang, Xu, Long, Qiong, Bai, Hongmei, Ma, Yanbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521720/ https://www.ncbi.nlm.nih.gov/pubmed/36189310 http://dx.doi.org/10.3389/fimmu.2022.991857 |
Ejemplares similares
-
Polymerized porin as a novel delivery platform for coronavirus vaccine
por: Yang, Zhongqian, et al.
Publicado: (2022) -
A "trained immunity" inducer-adjuvanted nanovaccine reverses the growth of established tumors in mice
por: Li, Duo, et al.
Publicado: (2023) -
Exploiting immunostimulatory mechanisms of immunogenic cell death to develop membrane-encapsulated nanoparticles as a potent tumor vaccine
por: Liu, Qingwen, et al.
Publicado: (2023) -
GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I/R Injury
por: Shi, Huairui, et al.
Publicado: (2021) -
GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis
por: Ye, Xiaomiao, et al.
Publicado: (2022)